Transfer Factors Using ImmunorehabilitationAfter Infectious-Inflammatory & Somatic DiseasesMETHODOLOGICAL LETTER
This communication presents the results of clinical trials, which were designed to study theeffectiveness of a complex colostrum derived product, Transfer Factor™ (and Transfer FactorPlus™), in various pathological conditions and to study the influence of cellular mediators,which are incorporated in Transfer Factor, on different components of the immune system.The authors give recommendations concerning the use of Transfer Factor products in medicalpractice.This methodology letter was considered and approved at the Central Coordination meeting of the Methodological Council of Altay State Medical University (protocol No 4, 05.11.2033)and sent to the Ministry of Health and Social Development of the Russian Federation for theirconsideration.
Academician A.A. Vorobiev, Russian Academy of Medical Sciences (RAMS), HonoredRussian Federation (RF) Scientist, Doctor of Immunology.Professors Iu.V. Telnukh, MD and E.O. Khalturina, MD, Sechenov Medical Academy,Moscow, HM, RF.Professor M.V. Kisielevsky, MD, Russian Blokhin Cancer Research Center, RAMS.Doctors N.V. Karbuishea, MD, Professor V.M. Granitov, and Associate Professors A.S.Khabarov, D.V. Kipriyanov, N.Iu. Raiu, Municipal Hospital #5, Altay State MedicalUniversity, Barnaul.Candidates of Medical Sciences L.V. Sultanov, E.Iu. Kozhevnikova, S.I. Belyikh, AltayRegional Center for AIDS Prevention and Control.Professors V.A. Dadli, A.V. Rak, E.S. Stolpnyik, Candidates G.A. Baslovich, L.B.Gaykovskaya, St Petersburg’s Mechnikov State Medical Academy.Doctors E. Oganova, MD and C.W. McCausland, PhD chemical sciences, 4Life Research,USA.Associate Professor G.M. Letifov, MD, Rostov State Medical University.
:Academician B.A. Tutelian, Director of RAMS Research Institute of Nutrition.Professor A.V. Karaulov, MD, Clinical Immunology Department, Sechenov MedicalAcademy, Moscow.